拒稿信汇总教学教材Word格式文档下载.docx
- 文档编号:20834847
- 上传时间:2023-01-25
- 格式:DOCX
- 页数:6
- 大小:18.98KB
拒稿信汇总教学教材Word格式文档下载.docx
《拒稿信汇总教学教材Word格式文档下载.docx》由会员分享,可在线阅读,更多相关《拒稿信汇总教学教材Word格式文档下载.docx(6页珍藏版)》请在冰豆网上搜索。
have
now
read
manuscript...
Unfortunately,
it
our
opinion
manuscript
be
strong
candidate
consideration
Hypotheses
would
as
appropriately
published
another
journal.
giving
us
opportunity
consider
work.
Yours
sincerely
Dr.
M.
Manku
PhD
Editor
Chief
各位前辈,由于急于毕业,文章投BBRC,5天后状态是completely
reject,拒稿理由很多且没有一句正面肯定的评论,而拒稿信中又说可以重投,我不理解既然我的文章一无是处,为什么还建议重投呢?
不知是不是我理解错了?
另外5天(包括周六、周日)就被拒了,是不是编辑给拒的,没有任何专家审过呢?
我该怎么办呢?
在线等待您的解答...(附部分拒稿信)
After
careful
review
manuscript,
am
afraid
we
able
accept
publication
BBRC
its
current
form.
As
know,
this
rapid
communication
journal
all
submissions,
regardless
their
merit,
suitable
format.
Our
standards
increasingly
high,
fact,
approximately
80%
submissions
do
meet
criteria.
..........
strongly
encourage
significantly
revise
based
on
above
commentary.
The
concerns
reviewer
should
addressed
point-by-point
cover
letter
changes
must
identified
page
paragraph,
noted
underlining
or
italics
text.
Please
submit
new
submission
note
will
assigned
same
editor.
SC
19:
36:
35
请问各位前辈我的文章被拒了,拒稿信如下:
over
believe
potential
interest
readers
Clinical
Biochemistry.
However
given
focused
work
best
format
Brief
Report
(Short
Communication)
rather
than
full
paper.
If
wish
please
reformat
according
journal'
s
Guide
Authors
short
communication.
resubmission
guarantee
acceptance
publication.
Biochemistry.
这样的Brief
Report和一般的文章有什么差别?
我还有必要把它改成Brief
再投吗,还是改投别的杂志?
谢谢了
最近老收到拒稿信,
有点伤感.
Dear
*
Lung
Cancer.
We
regret
advise
after
several
unsucessful
attempts
external
review,
decided
publish
contribution
receive
considerably
more
manuscripts
room
publish,
so
competition
space
intense.
Although
was
successful
occasion,
hope
put
off
from
considering
Cancer
future
submissions.
Rolf
Stahel
Editor-in-Chief
投稿三个半月,只等到一封拒稿信,我能去信要审稿人的评论么?
不甘心呀!
外文审稿不是应该都给作者审稿人的评论吗?
x,
x
x.
has
been
through
process.
cannot
sufficient
priority
to
allow
publication.
content
submitted
represent
a
focus
area
journal.
better
directed
journal
other
DRCP.
sorry
disappoint
occasion.
allowing
we
very
much
further
group
in
future.
sincerely,
xxxxxxxxxxx
38:
38
Hu:
write
regards
#
09-09-0539
entitled
"
##"
which
Pharmacology
Therapeutics.
that,
view
assessmentof
reviewerfound
at
bottom
letter,
selected
receives
many
high-quality
can
Editorial
Team,
context
comments,
identify
most
impactful
limited
available.
Therapeutics
research.
outcome
specific
discourage
manuscripts,
success
achieving
elsewhere.
Sincerely,Scott
A.
Waldman
Chief,
Therapeutics
cpteditor@ascpt.org
Reviewer'
Comments
Author:
Reviewer:
1
Author
This
meta-analysis
addresses
an
important
clinical
question
about
####
drug
metabolism
CYP450.
methodology
used
conduct
analysis
appears
appropriate.
could
improved
addressing
limitations
discussion
section
expressing
findings
concisely.
An
assessment
quality
individual
studies
also
helpful
interpreting
meta
analysis.
2
Hu
Zhao
“##”
examines
influence
##
hepatic
intestinal
considerable
there
sporadic
reports
expression
CYP450
sites.
Reference
11
subset
individuals
presented
25.
Data
reference
(abstract)
meta-analysis.
It
unclear
if
differences
route
administration
(IV
push
versus
IV
infusion)
affect
comment
known
significant
difference
body
weight
between
males
females
how
affects
study.
A
fixed
order
design
such
those
employed
References
4,
16,
24,
25
considered
randomized
studies.
09-Nov-2009
revised
version
(09-09-0539)
response
Associate
team
and,
regrettably,
decision
further.
aware
addition
referees
who
felt
although
topic
interest,
specialized
Due
number
currently
receiving,
editors
tasked
with
selecting
papers
available
rarely
allowed.
elsewhere.
Sincerely,
Scott
WaldmanEditor
Chief,
Therapeuticscpteditor@ascpt.org
39:
44
Dr
*,
unable
manuscript.
carefully
reviewed
editorial
team,
basis
already
accepted,
unlikely
include
International
Journal
Cardiology
To
avoid
any
unnecessary
delay
sending
back
elsewhere
wish.
however
feel
might
publishing
Letter
like
re-submit
pleased
look
again.
Letters
need
restricted
1000
words.
They
title
page,
abstract,
main
text
references.
最近投了International
Cardiology,IF两点多,从投稿到今天被拒将近两个月一直都是with
editor状态,郁闷啊。
我想问一下如果我按照这个信里说得以letter形式修改后再投过去的话,被接受的可能性有多大呢?
我的第一篇SCI,已经被拒了N次了,现在只要能发出去就行,不管啥形式。
请有经验的朋友指导一下,谢谢!
received
report
first
among
leading
experts
field
xxx.
expecting
2nd
next
few
days.
see
attached
report,
raised
some
serious
questions
interpretation.
In
case
won'
t
xxx
even
less
critical.
only
where
editor
enthusiastic
prevent
paper,
returning
resubmit
Meanwhile
send
soon
reaches
me.
看了审稿意见
真是哪哪都不好,难道我自己对文章的评价是如此失误么,我知道这个杂志对我的文章来说是高攀了,但是我不觉得我的文章一无是处,现在看到这个结果真的不想改了。
觉得没有价值了,大家帮帮我把,我还有改的意义么,肯定是比不了业得了。
40:
46
Regrettably,
however,
Journal,
mainly
because
lack
pages
printing,
reflected
present
percentage
around
15
forces
selective,
thanking
no
lot
good
papers,
own.
Moreover,
high
XXX
allied
topics
making
competitio
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 信汇 教学 教材